A call for 6 PhD positions with three-year funding is open in the recently granted Marie Skłodowska-Curie Innovative Training Network (MSCA-ITN) project DELIVERy of advanced therapies for diabetes training network. The Early Stage Researchers [ESRs]) will spend 50% of their training with one of the industry partners. DELIVER is a major interdisciplinary effort between cell biologists, experts in biomaterials, medical devices and advanced drug delivery, clinical experts and biotech and biomedical companies focused on academic training and spearheading innovative medical devices for insulin producing cell transplantation.
The network will enable innovative medical devices for pancreatic islet transplantation, a cell therapy poised to become more widespread in the treatment of insulin-dependent diabetes. The project will train early stage researchers in the field of advanced therapies and at the same time, develop their innovative and entrepreneurial capacity, their communication and leadership skills, and their commercial awareness, allowing for a career in both academia and industry.